JP2020527546A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020527546A5 JP2020527546A5 JP2019572724A JP2019572724A JP2020527546A5 JP 2020527546 A5 JP2020527546 A5 JP 2020527546A5 JP 2019572724 A JP2019572724 A JP 2019572724A JP 2019572724 A JP2019572724 A JP 2019572724A JP 2020527546 A5 JP2020527546 A5 JP 2020527546A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- peptide
- amino acid
- acid sequence
- tlr7
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2017902545 | 2017-06-30 | ||
| AU2017902545A AU2017902545A0 (en) | 2017-06-30 | A method of treatment | |
| PCT/AU2018/050667 WO2019000045A1 (en) | 2017-06-30 | 2018-06-29 | METHOD OF TREATMENT |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020527546A JP2020527546A (ja) | 2020-09-10 |
| JP2020527546A5 true JP2020527546A5 (https=) | 2021-07-29 |
Family
ID=64740713
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019572724A Pending JP2020527546A (ja) | 2017-06-30 | 2018-06-29 | 治療方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US11319343B2 (https=) |
| EP (1) | EP3645030A4 (https=) |
| JP (1) | JP2020527546A (https=) |
| CN (2) | CN119548615A (https=) |
| AU (1) | AU2018293925B2 (https=) |
| WO (1) | WO2019000045A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2018293925B2 (en) * | 2017-06-30 | 2024-06-13 | Adelaide university | A method of treatment |
| WO2022170396A1 (en) * | 2021-02-12 | 2022-08-18 | ViraLok Therapeutics Pty Ltd | Agents and methods for therapy and prophylaxis |
| CN114532296B (zh) * | 2021-12-14 | 2023-12-15 | 首都医科大学附属北京同仁医院 | NOX2基因缺陷rd1小鼠模型及其制备方法和应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ525914A (en) * | 1998-03-10 | 2004-03-26 | Genentech Inc | Novel polypeptides and nucleic acids encoding the same |
| JP2005500806A (ja) * | 2000-09-15 | 2005-01-13 | コーリー ファーマシューティカル ゲーエムベーハー | ＣｐＧに基づく免疫アゴニスト／免疫アンタゴニストの高スループットスクリーニングのためのプロセス |
| CA2732799A1 (en) * | 2008-08-04 | 2010-02-11 | Idera Pharmaceuticals, Inc. | Modulation of toll-like receptor 7 expression by antisense oligonucleotides |
| EP2582398B1 (en) * | 2010-06-16 | 2016-04-13 | Dynavax Technologies Corporation | Methods of treatment using tlr7 and/or tlr9 inhibitors |
| US20140378531A1 (en) * | 2012-02-01 | 2014-12-25 | New York University | Inhibition of pattern recognition receptors in pancreatic cancer treatment using tlr inhibitors |
| US9228184B2 (en) * | 2012-09-29 | 2016-01-05 | Dynavax Technologies Corporation | Human toll-like receptor inhibitors and methods of use thereof |
| US10370451B2 (en) * | 2013-04-22 | 2019-08-06 | The University Of Tokyo | Preventive or therapeutic agent for inflammatory disease |
| CN104211799B (zh) * | 2013-05-29 | 2017-12-26 | 成都渊源生物科技有限公司 | 人源egf结构域蛋白及其应用 |
| AU2014310935B2 (en) * | 2013-08-21 | 2019-11-21 | CureVac SE | Combination vaccine |
| WO2015195947A1 (en) * | 2014-06-20 | 2015-12-23 | Yale University | Compositions and methods to activate or inhibit toll-like receptor signaling |
| AU2018293925B2 (en) * | 2017-06-30 | 2024-06-13 | Adelaide university | A method of treatment |
-
2018
- 2018-06-29 AU AU2018293925A patent/AU2018293925B2/en active Active
- 2018-06-29 US US16/624,367 patent/US11319343B2/en active Active
- 2018-06-29 WO PCT/AU2018/050667 patent/WO2019000045A1/en not_active Ceased
- 2018-06-29 CN CN202411599223.4A patent/CN119548615A/zh active Pending
- 2018-06-29 JP JP2019572724A patent/JP2020527546A/ja active Pending
- 2018-06-29 EP EP18823595.6A patent/EP3645030A4/en active Pending
- 2018-06-29 CN CN201880056934.3A patent/CN111417401A/zh active Pending
-
2022
- 2022-03-24 US US17/703,111 patent/US20220213143A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6995933B2 (ja) | インターロイキン２３受容体の経口ペプチド阻害剤および炎症性腸疾患を処置するためのそれらの使用 | |
| Splith et al. | Antimicrobial peptides with cell-penetrating peptide properties and vice versa | |
| US8785375B2 (en) | Cyclic antimicrobial peptides for treating bacterial infections | |
| JP2014525901A5 (https=) | ||
| JP2014524908A5 (https=) | ||
| JP2020527546A5 (https=) | ||
| CA3049889A1 (en) | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases | |
| JP2011524420A5 (https=) | ||
| HRP20170890T1 (hr) | Suagonisti glukagonskog/glp-1 receptora | |
| JP5753077B2 (ja) | 抗菌ペプチド多量体 | |
| HRP20141215T1 (hr) | Analozi oksintomodulina | |
| HRP20210809T1 (hr) | Biciklični peptidni ligandi specifični za mt1-mmp | |
| JP2012529297A5 (https=) | ||
| JP2012508698A5 (https=) | ||
| US20160168203A1 (en) | Cyclic Antimicrobial Peptides | |
| JP2008522954A5 (https=) | ||
| WO2013134249A1 (en) | Adipose tissue targeted peptides | |
| JP7333929B2 (ja) | ヒスタチンおよびその使用方法 | |
| CN114644687A (zh) | 一种可拮抗rbm25蛋白rna结合活性的多肽rbip-21及其应用 | |
| US6713078B2 (en) | Retrocyclins: antiviral and antimicrobial peptides | |
| JP2015533372A5 (https=) | ||
| JP7489319B2 (ja) | 細胞膜透過性ペプチド | |
| Toshchakov | Peptide-based inhibitors of the induced signaling protein interactions: current state and prospects | |
| EP1389126B1 (en) | Retrocyclins: antiviral and antimicrobial peptides | |
| JP2024527220A5 (https=) |